Selected research
Market Outlook & Growth Opportunities
Global Histrelin Market Outlook and Growth Opportunities 2026
Market perspective
The global Histrelin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Histrelin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Histrelin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Histrelin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Histrelin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Histrelin market include Endo Pharmaceuticals. among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Histrelin market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Histrelin and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Histrelin revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Histrelin market.
Histrelin Segment by Company
Endo Pharmaceuticals
Histrelin Segment by Type
Supprelin LA
Vantas
Histrelin Segment by Application
Boy
Girl
Histrelin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Histrelin status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Histrelin key companies, revenue, market share, and recent developments.
3. To split the Histrelin breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Histrelin market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Histrelin significant trends, drivers, influence factors in global and regions.
6. To analyze Histrelin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histrelin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Histrelin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histrelin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Histrelin industry.
Chapter 3: Detailed analysis of Histrelin company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Histrelin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Histrelin in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Supprelin LA
- Vantas
Applications
- Boy
- Girl
Companies covered
- Endo Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Histrelin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Histrelin Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Histrelin Market Dynamics
- 2.1 Histrelin Industry Trends
- 2.2 Histrelin Industry Drivers
- 2.3 Histrelin Industry Opportunities and Challenges
- 2.4 Histrelin Industry Restraints
3 Histrelin Market by Company
- 3.1 Global Histrelin Company Revenue Ranking in 2025
- 3.2 Global Histrelin Revenue by Company (2021-2026)
- 3.3 Global Histrelin Company Ranking (2024-2026)
- 3.4 Global Histrelin Company Manufacturing Base and Headquarters
- 3.5 Global Histrelin Company Product Type and Application
- 3.6 Global Histrelin Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Histrelin Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Histrelin Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Histrelin Market by Type
- 4.1 Histrelin Type Introduction
- 4.1.1 Supprelin LA
- 4.1.2 Vantas
- 4.2 Global Histrelin Sales Value by Type
- 4.2.1 Global Histrelin Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Histrelin Sales Value by Type (2021-2032)
- 4.2.3 Global Histrelin Sales Value Share by Type (2021-2032)
5 Histrelin Market by Application
- 5.1 Histrelin Application Introduction
- 5.1.1 Boy
- 5.1.2 Girl
- 5.2 Global Histrelin Sales Value by Application
- 5.2.1 Global Histrelin Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Histrelin Sales Value by Application (2021-2032)
- 5.2.3 Global Histrelin Sales Value Share by Application (2021-2032)
6 Histrelin Regional Value Analysis
- 6.1 Global Histrelin Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Histrelin Sales Value by Region (2021-2032)
- 6.2.1 Global Histrelin Sales Value by Region: 2021-2026
- 6.2.2 Global Histrelin Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Histrelin Sales Value (2021-2032)
- 6.3.2 North America Histrelin Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Histrelin Sales Value (2021-2032)
- 6.4.2 Europe Histrelin Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Histrelin Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Histrelin Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Histrelin Sales Value (2021-2032)
- 6.6.2 South America Histrelin Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Histrelin Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Histrelin Sales Value Share by Country, 2025 VS 2032
7 Histrelin Country-level Value Analysis
- 7.1 Global Histrelin Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Histrelin Sales Value by Country (2021-2032)
- 7.2.1 Global Histrelin Sales Value by Country (2021-2026)
- 7.2.2 Global Histrelin Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Histrelin Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Histrelin Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Histrelin Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Histrelin Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Histrelin Sales Value Growth Rate (2021-2032)
- 7.7.2 France Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Histrelin Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Histrelin Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Histrelin Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Histrelin Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Histrelin Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Histrelin Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Histrelin Sales Value Growth Rate (2021-2032)
- 7.14.2 China Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Histrelin Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Histrelin Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Histrelin Sales Value Growth Rate (2021-2032)
- 7.17.2 India Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Histrelin Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Histrelin Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Histrelin Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Histrelin Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Histrelin Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Histrelin Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Histrelin Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Histrelin Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Histrelin Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Histrelin Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Histrelin Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Histrelin Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Histrelin Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Histrelin Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Histrelin Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Histrelin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Endo Pharmaceuticals
- 8.1.1 Endo Pharmaceuticals Company Information
- 8.1.2 Endo Pharmaceuticals Business Overview
- 8.1.3 Endo Pharmaceuticals Histrelin Revenue and Gross Margin (2021-2026)
- 8.1.4 Endo Pharmaceuticals Histrelin Product Portfolio
- 8.1.5 Endo Pharmaceuticals Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst